By William J. Judge, JD, LL.M., and Nick Hartman, Drug Screening Compliance Institute Background It has been estimated that as many as 45 million workplace drug tests are conducted each year in the United States. The most recent Quest Diagnostics Drug Testing Index...
Featured posts
All posts
Fentanyl and fentanyl analogs: Prevalence and challenges
By Sabra Jones and Chris Heartsill, Regional Toxicology Liaisons, National Highway Traffic Safety Administration, Regions 5 and 7 Per the Centers for Disease Control, overdose deaths remain the leading cause of injury-related deaths in the United States1 and fentanyl...
“They never trained me for this!” What to do if what happens during the collection is not in the regulations
By Patrice Kelly, Senior Policy Executive Adviser, NDASA, (on detail from the US Department of Transportation) The United States Department of Transportation (DOT) regulation, 49 CFR Part 40 (Part 40), and most collector training courses are written to address what...
NDASA’s public comments on the proposed rescheduling of marijuana – Part 1
The Honorable Merrick B....
Model Standing Order for drug testing of DOT-regulated employees
Under the DOT’s oral fluid final rule, DOT says employers must tell collection sites what kind of testing methodology to use (oral fluid versus urine), recommending that employers have a "Standing Order" in place to avoid any confusion in the testing process....
Is your MFR ready?
A reminder to drug and alcohol screening businesses, collectors, TPAs and other involved in drug screening: If you conduct U.S. Department of Transportation mandated testing, the 2017 federal Custody and Control Form expires at the end of August 2021. The new (2020)...
Meet The Institute for Behavior and Health
The Institute for Behavior and Health, Inc., is a nonprofit organization based in Rockville, Md., that develops strategies to reduce drug use. President Robert L. DuPont, M.D., was the lead author on an extensive 2015 report titled, “Workplace Drug Testing in the Era...
U.S. DOT Recreational Marijuana Notice
“We want to make it perfectly clear that the state initiatives will have no bearing on the Department of Transportation’s regulated drug testing program. The Department of Transportation’s Drug and Alcohol Testing Regulation – 49 CFR Part 40 – does not authorize the...
U.S. DOT Medical Marijuana Notice
“Medical Review Officers will not verify a drug test as negative based upon information that a physician recommended that the employee use “medical marijuana.” Please note that marijuana remains a drug listed in Schedule I of the Controlled Substances Act. It remains...
Meet the National Marijuana Initiative
The National Marijuana Initiative (NMI) is one of three national initiatives within the federal High Intensity Drug Trafficking Areas (HIDTA) Program. The White House Office of National Drug Control Policy has established HIDTA task forces all over the country to...